Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Industry
China compiles medicine list to guide doctors2010-02-09
Guangdong Yili finished biggest production base of TCM abstracts2010-02-09
SFDA approved Sinobiopharma's Perindopril for hypertension2010-02-03
Novo Nordisk awaits China approval Victoza for Diabetes2010-02-03
Export rebates of some antibiotics reduce to 13%2010-02-01
Distribution of China Pharmacopoeia (2010) begins2010-01-27
Gaoke Vitamin C item passed environmental examination2010-01-25
SFDA raises standards for the approval of generic drugs2010-01-21
China to open up pharmaceutical market for Indian companies2010-01-20
Commerce Ministry reminds anti-dumping duty may be extended2010-01-19
New Vitamin B6 project started construction in Hubei2010-01-19
Crinone (Progesterone Gel) launched in China2010-01-13
China encourages the expansion of chain drugstores2010-01-12
China's vaccine market expected to expand quickly2010-01-11
Butylphthalide won 2nd class prize of National S&T Progress2010-01-11
SFDA strengthens medical sodium hyaluronate products management2010-01-07
Aoxing finished phase II study of TJSL capsules for dysmenorrhea2010-01-06
NDRC five measures to restrain the expansion of Vitamin C industry2009-12-31
Ranbaxy to sell Chinese subsidiary to HNG Chembio2009-12-30
Eli Lilly launched small package of Alimta in China2009-12-29
Anhui invested 1.3 bn in grass-roots medical system in 20092009-12-28
Astellas lanuches Vesicare in China for OAB2009-12-25
MSD expects better China sales2009-12-25
Boehringer Ingelheim launched Micardis Plus in China2009-12-24
Zanamivir listed into drug catalogue of medical insurance in Jiangxi2009-12-15
Takeda and Pfizer to co-promote Actos (pioglitazone HCl) in China2009-12-15
Lilly aims to increase its pharmaceutical presence in China2009-12-15
Phase 3 trial of Stimuvax in Asian patients with NSCLC started2009-12-11
Export volume of Taurine expected to 12000 ton in China2009-12-10
SFDA strengthens the management of ephedrine proudct2009-12-10
Seretide Evohaler's drug administrative protection expired2009-12-08
Aerius's drug administrative protection expired2009-12-08
共1471个 页次:31/46页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463